BIM deletion polymorphism profiling complements prognostic values of risk scores in imatinib-treated Asian chronic myeloid leukemia patients.

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Than, H; Lye, WK; Sng, C; Allen, JC; Ong, ST; Chuah, C

Published Date

  • January 2019

Published In

Volume / Issue

  • 60 / 1

Start / End Page

  • 234 - 237

PubMed ID

  • 29916288

Pubmed Central ID

  • 29916288

Electronic International Standard Serial Number (EISSN)

  • 1029-2403

Digital Object Identifier (DOI)

  • 10.1080/10428194.2018.1461863

Language

  • eng

Conference Location

  • United States